Health
STAT+: Pharmalittle: We’re reading about a Novo setback in court, a House probe into big PBMs, and more
A U.S. judge rejected a bid to block Eli Lilly from running what Novo Nordisk claims is a “deceptive” advertising campaign about weight loss drugs
- Published
- (1 h ago)
- Outlet
- STAT News
- Section
- Health
- Length here
- Headline and 25-word snippet. The full article is at the source.
More from STAT News and around the same time
A possible treatment for brain-eating amoebas, found in the seaBrain-eating amoebas are hard to treat and nearly always fatal. But researchers have isolated a compound that could help stop the disease.Opinion: Cancer vaccines are finally here. How do we get them to patients?“If we want cancer vaccines to reach patients faster than BRCA testing did, there are several challenges to address now,” write Karen E. Knudsen and Othman Laraki.Opinion: Emergency pediatric care is now in permanent crisis mode“In 2026, the unprecedented pediatric patient crowding of 2022 has become a normal Tuesday,” write Jonathan Kohler and Mary King.STAT+: Pennsylvania Dutch country, tired of waiting for biopharma, builds drug company of its ownA small community tests if it can solve a crisis no one else could, for the simple reason that they have no other choice.STAT+: Roche gets a lung cancer win with its KRAS drug divarasibOne of the more impressive data sets at this year’s ESMO came from a Roche study of its drug divarasib, which treats lung cancer.STAT+: Nonprofit Bon Secours Mercy Health strikes $5.7 billion deal for surgery center chainThe deal would make the Catholic system one of the largest operators of outpatient surgery centers.This page holds the headline and a short snippet as published by STAT News, whose feed they came from. The story itself, the photography and the rights stay with them, and the button above goes straight to their site. We keep this page so the headline has a stable address and a record of when it ran.
